{"References": [{"title": "Hypoxia-inducible factor prolyl hydroxylase inhibitors in the treatment of anemia in chronic kidney disease", "authors": "Bernhardt WM, Wiesener MS, Weidemann A, Warnecke C, Arend M, Klaus S, GÃ¼nzler V, Eckardt KU", "journal": "American Journal of Nephrology", "year": "2010", "volumes": "32", "first page": "347", "last page": "359", "DOI": "10.1159/000319828"}, {"title": "HIF prolyl hydroxylase inhibitors for anemia in chronic kidney disease", "authors": "Haase VH", "journal": "New England Journal of Medicine", "year": "2013", "volumes": "369", "first page": "60", "last page": "62", "DOI": "10.1056/NEJMcibr1304899"}, {"title": "Erythropoiesis and iron metabolism in chronic kidney disease: the role of inflammation", "authors": "Babitt JL, Lin HY", "journal": "Nature Reviews Nephrology", "year": "2012", "volumes": "8", "first page": "151", "last page": "159", "DOI": "10.1038/nrneph.2011.169"}, {"title": "Hypoxia-inducible factors and anemia in chronic kidney disease", "authors": "Semenza GL", "journal": "Nature Reviews Nephrology", "year": "2014", "volumes": "10", "first page": "653", "last page": "662", "DOI": "10.1038/nrneph.2014.185"}, {"title": "The role of hypoxia-inducible factors in renal fibrosis", "authors": "Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH", "journal": "Nature Medicine", "year": "2007", "volumes": "13", "first page": "952", "last page": "960", "DOI": "10.1038/nm1613"}, {"title": "Erythropoietin and the regulation of erythropoiesis in the hypoxic kidney", "authors": "Haase VH", "journal": "American Journal of Physiology-Renal Physiology", "year": "2010", "volumes": "299", "first page": "F11", "last page": "F24", "DOI": "10.1152/ajprenal.00160.2010"}, {"title": "HIF stabilization reduces erythropoietin and increases hemoglobin despite iron deficiency in an animal model of chronic kidney disease", "authors": "Nangaku M, Eckardt KU", "journal": "Journal of the American Society of Nephrology", "year": "2013", "volumes": "24", "first page": "1231", "last page": "1241", "DOI": "10.1681/ASN.2012101008"}, {"title": "Pharmacologic targeting of the HIF hydroxylases for the treatment of anemia in chronic kidney disease", "authors": "Sanghani NS, Haase VH", "journal": "Current Opinion in Nephrology and Hypertension", "year": "2019", "volumes": "28", "first page": "600", "last page": "606", "DOI": "10.1097/MNH.0000000000000555"}, {"title": "Erythropoiesis-stimulating agents and the risk of thrombosis in patients with chronic kidney disease", "authors": "Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Nicolucci A, Strippoli GF", "journal": "Cochrane Database of Systematic Reviews", "year": "2014", "volumes": "1", "first page": "CD003266", "last page": "", "DOI": "10.1002/14651858.CD003266.pub3"}, {"title": "Hypoxia-inducible factor prolyl hydroxylase inhibitors: a new therapeutic class for the treatment of anemia of chronic kidney disease", "authors": "Sanghani NS, Haase VH", "journal": "Clinical Journal of the American Society of Nephrology", "year": "2019", "volumes": "14", "first page": "130", "last page": "140", "DOI": "10.2215/CJN.02520318"}]}